Paul Sax, MD, FIDSA and clinical trialist extraordinaire David Boulware, MD, MPH, FIDSA discuss promising studies of interferon lambda, metformin, and ensitrelvir for COVID-19 -- and why none of them is currently in treatment guidelines. *This episode was recorded before the Paxlovid EPIC-SR results <a href='https://www.fda.gov/media/166197/download'>were released in an FDA briefing</a>.

Paul Sax, MD, FIDSA and clinical trialist extraordinaire David Boulware, MD, MPH, FIDSA discuss promising studies of interferon lambda, metformin, and ensitrelvir for COVID-19 -- and why none of them is currently in treatment guidelines. *This episode was recorded before the Paxlovid EPIC-SR results were released in an FDA briefing.

Paul Sax, MD, FIDSA and clinical trialist extraordinaire David Boulware, MD, MPH, FIDSA discuss promising studies of interferon lambda, metformin, and ensitrelvir for COVID-19 -- and why none of them is currently in treatment guidelines. *This episode was recorded before the Paxlovid EPIC-SR results <a href="https://www.fda.gov/media/166197/download" rel="noopener noreferrer">were released in an FDA briefing</a>.

Three effective treatments for COVID-19 not (yet) in guidelines

Let's Talk ID is a podcast by the Infectious Diseases Society of America, featuring discussions with experts on a range of topics related to infectious diseases including antimicrobial resistance, ID diagnostics and outbreaks such as COVID-19, Ebola and measles. Episodes on IDSA’s guidelines are also available.*The views and opinions expressed in this podcast are those of the speakers and do not necessarily reflect the views or positions of the Infectious Diseases Society of America.&nbsp;

Science

Medicine

Health & Fitness

Life Sciences

Let's Talk ID is a podcast by the Infectious Diseases Society of America, featuring discussions with experts on a range of topics related to infectious diseases including antimicrobial resistance, ID diagnostics and outbreaks such as COVID-19, Ebola and measles. Episodes on IDSA’s guidelines are also available.*The views and opinions expressed in this podcast are those of the speakers and do not necessarily reflect the views or positions of the Infectious Diseases Society of America. 

Share Three effective treatments for COVID-19 not (yet) in guidelines

Sign up to save your podcasts

Three effective treatments for COVID-19 not (yet) in guidelines

Three effective treatments for COVID-19 not (yet) in guidelines

More shows like Let's Talk ID

JAMA Editors' Summary

This Week in Virology

NEJM This Week

This Week in Microbiology

JAMA Clinical Reviews

This Week in Virology

Mayo Clinic Talks

The Curbsiders Internal Medicine Podcast

Core IM | Internal Medicine Podcast

Annals On Call Podcast

The Clinical Problem Solvers

Breakpoints

The Curious Clinicians

Febrile

Infectious Disease Puscast